Saxenda Shortage Update December 2024. On december 12, 2023, novo nordisk released a statement, addressing the shortage of specifically the wegovy 1.7 mg dose in the united states, saying it expected to resume. Wegovy pulled down 1.18 billion danish kroner ($161 million) in 2022’s second quarter, while saxenda sales grew an impressive 29% to about 2.5 billion.
Saxenda will have limited availability through the end of 2023. There is insufficient supply for usual ordering;
On December 12, 2023, Novo Nordisk Released A Statement, Addressing The Shortage Of Specifically The Wegovy 1.7 Mg Dose In The United States, Saying It Expected To Resume.
Novo nordisk has saxenda on shortage due to increased demand.
But Don't Worry, Uk Meds.
This time it’s the weight loss drug liraglutide, better known as saxenda.
The Increased Demand For This.
Images References :
But Don't Worry, Uk Meds.
Novo nordisk a/s ’s drug saxenda is the latest to hit a shortage, as high demand for weight loss drugs sparks supply snags across the industry.
— News And Commentary From The Endocrinology World.
This time it’s the weight loss drug liraglutide, better known as saxenda.
The Weight Loss Drug Saxenda (Liraglutide) Is Facing Potential Shortages Through The End Of 2023, As Reported By The Fda’s Drug Shortages Tracker.
